Hansard
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 1 of 1
View Daniel Blaikie Profile
NDP (MB)
View Daniel Blaikie Profile
2020-03-12 12:44 [p.1999]
Madam Speaker, there has been a lot of debate, discussion and research on how medication for rare diseases is a separate category and needs to be treated differently. The idea is not that a national pharmacare plan would be a panacea for every patient and for every condition. The fact of the matter is, as the member has been pointing out often in the House and not just in the debate today, people already have trouble accessing those drugs in Canada under a patchwork system. That is not a reason not to have a system that makes it a lot easier and a lot cheaper to access common drugs for most Canadians, and then work on an appropriate solution for people who are struggling to get access to medication for rare diseases.
The member sees these two things as being in fundamental opposition. I disagree. He is identifying a legitimate need that needs a policy response, but the policy response is not to negate all of the benefits of a national pharmacare plan.
Result: 1 - 1 of 1

Export As: XML CSV RSS

For more data options, please see Open Data